Companies / Cuba
Cubans Launch Diabetic Foot Ulcer Drug
May 2006 | Project NewsAccording to media reports, Cuban manufacturers have synthesised a new drug for diabetic foot ulcers. The product, known as Citoprot-P, enables epidermal growth factor to alleviate lesions and prevents the necessity of amputation, claims Havana-based biotech institute CIGB. The technology has also been developed by producers in other emerging markets, notably including South
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
